The aim of this study was to identify prognostic factors in patients undergoing pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma. The records of 46 consecutive patients with ampullary carcinoma who underwent pancreatoduodenectomy from 1988 through 2006 were retrospectively reviewed. A 98% rate of potentially curative (R0) resection was achieved. There was no 30-day mortality. Overall 5-year survival rate was 64%. Univariate analysis revealed that T3 and T4 tumor (i.e., pancreatic parenchymal invasion) (P \ 0.001), lymph node metastasis (P = 0.01), and perineural invasion (P \ 0.001) were significant predictors of poor prognosis. Furthermore, perineural invasion was found to be a significant independent predictor of poor prognosis by multivariate analysis (P = 0.024). Pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma is a safe surgical procedure with an acceptable cure rate. The presence of perineural invasion may be useful for predicting poor prognosis in patients with ampullary carcinoma who undergo potentially curative resection.
Introduction
Ampullary carcinoma is an uncommon type of periampullary tumor with a more favorable prognosis than other tumors arising in this location [1, 2] . The improved prognosis of this condition compared to pancreatic or biliary adenocarcinomas is thought to result in part from its higher rate of resectability, which can be achieved in over 80% of cases [1, 3, 4] . However, some patients eventually succumb to the disease, with 5-year survival rates following resection ranging from 38 to 67% [1, [3] [4] [5] [6] [7] [8] [9] . Many predictive factors have been reported to influence survival following ampullary carcinoma resection, including depth of tumor infiltration [5, 7, 9, 10] , lymph node metastasis [1, 4, 6, [9] [10] [11] [12] , TNM stage [5, 8] , pancreatic invasion [4, 12] , and perineural invasion [13, 14] . Identification of predictors of failure and survival following potentially curative resection should enable selection of candidates for adjuvant treatment. The objectives of this single-center review were to determine the cure rate of patients who underwent pancreatoduodenectomy with standard regional lymphadenectomy for ampullary carcinoma and to identify which clinicopathologic variables may be associated with longterm survival in this patient population. confirmed preoperative pathological diagnosis. All patients were Japanese, and included 27 men and 19 women of median age 69 (range, 22-82) years.
Operative procedures
Pylorus-preserving pancreatoduodenectomy was performed for 39 patients, and conventional Whipple's procedure was performed for seven patients. All 46 patients underwent pancreatoduodenectomy with standard regional lymphadenectomy, with dissection of lymph nodes in the peripancreatic area, lower hepatoduodenal ligament, and along the right lateral aspect of the superior mesenteric artery and vein. However, aorto-caval nodes (celiac artery to inferior mesenteric artery) were dissected only when visibly swollen. Reconstruction was performed with pancreaticogastrostomy, hepaticojejunostomy, and duodenojejunostomy or gastrojejunostomy. The surgery was performed by a single team of experienced hepatobiliarypancreatic surgeons during the 18-year study period.
Pathological investigations
All resected specimens were examined pathologically with hematoxylin and eosin staining. The tumors were classified as papillary adenocarcinoma, tubular adenocarcinoma, or others. Pancreatic parenchymal invasion, duodenal invasion, perineural invasion, and lymph node metastasis were determined through pathological examination. Tumor depth (T) and nodal status (N) were determined using standard TNM classification [15] . Regional lymph nodes used for nodal status determination included the anterior and posterior pancreaticoduodenal nodes, those in the lower hepatoduodenal ligament, and those along the right lateral aspect of the superior mesenteric artery and vein [16] .
Survival
Patients were followed regularly in outpatient clinics by undergoing computed tomography every 6 months for 5 years after surgery. Information on outcomes more than 5 years after surgery was collected by telephone or personal interview. If a patient died, the duration of survival after surgery and the cause of death were recorded. For surviving patients, postoperative survival time and status of recurrence were recorded. Disease-specific survival analyses with respect to three clinical factors (age, surgical procedure, and blood transfusion) and six pathological factors (tumor size, gross appearance, histological type, T score, N score, and perineural invasion) were performed using univariate and multivariate methods.
Statistical analysis
Survival curves were estimated by the Kaplan-Meier method, and statistical differences among groups were detected by log-rank test. Factors found to be statistically significant by univariate analysis were subjected to multivariate analysis with the Cox proportional hazards model. P values \0.05 were considered to be statistically significant.
Results

Operative results
The median operative time was 320 min (range, 230-500 min). Median estimated blood loss was 1,220 g (range, 150-5,980 g). Of the 46 patients, 14 (30%) required perioperative blood transfusion. There was no 30-day mortality. Overall morbidity was 37% (17 of 46 patients). Delayed gastric emptying was the most common complication (n = 6; 13%), followed by surgical site infection (n = 5; 11%), pancreatic fistula (n = 3; 7%), pneumonia (n = 2; 4%), enteritis (n = 2; 4%), bile leakage (n = 1; 2%), and chylous ascites (n = 1; 2%) ( Table 1) . None of the patients required subsequent surgery. The median size of resected ampullary carcinomas was 1.9 cm (range, 0.5-6.2 cm). Gross tumor appearance was the protruding type in 35 patients and the ulcerating type in 11 patients. Tumor types included 32 tubular adenocarcinomas, ten papillary adenocarcinomas, two mucinous adenocarcinomas, and two others. Pathologically, pancreatic parenchymal invasion and duodenal invasion were identified in 14 and 20 patients, respectively. Thirty-two patients had T1 or T2 tumors, while 14 had T3 or T4 tumors. The median number of resected lymph nodes was 20 (range, 5-107). Fifteen patients (33%) had lymph node metastasis. The lymph nodes in the peripancreatic area were most frequently involved, followed by nodes surrounding the superior mesenteric artery and nodes in the lower hepatoduodenal ligament. Perineural invasion was pathologically identified in 15 patients. Tumor staging was performed according to TNM criteria [15] ; there were 22 stage IA tumors, 4 stage IB tumors, 5 stage IIA tumors, and 15 stage IIB tumors. Only one patient had pathologically tumor-positive surgical margins; thus, a 98% rate of potentially curative (R0) resection was achieved.
Survival outcomes
The median follow-up time was 86 months. The estimated overall 5-year survival rate for the 46 patients was 64% (Fig. 1) . Recurrent disease occurred in 11 patients. Sites and nature of recurrence included liver metastases (n = 6), peritoneal dissemination (n = 3), and local disease (n = 2). Eighteen patients survived for more than 5 years after surgery, while fourteen patients died within 5 years. Of these 14 patients, four died of other disease, including 1 case each of primary lung carcinoma, renal cell carcinoma, gastric adenocarcinoma, and unknown sudden death with no evidence of recurrence. The estimated disease-specific 5-year survival rate for all 46 patients was 73% (Fig. 2) .
Univariate analysis revealed that T3 and T4 tumors (P \ 0.001), positive nodal status (P = 0.01), and presence of perineural invasion (P \ 0.001) were significantly associated with disease-specific survival (Table 2) . Median survival for patients with T3 and T4 tumors, lymph node metastasis, and perineural invasion was 11.5, 12.4, and 10.6 months, respectively. However, only perineural invasion maintained a significantly independent association with disease-specific survival (P = 0.024) on multivariate analysis (Table 3 ). The disease-specific 5-year survival rates of patients with or without perineural invasion were 26 and 94%, respectively (Fig. 3) .
Discussion
In this single-center experience, we have demonstrated that a radical surgical approach to ampullary carcinomas including pancreatoduodenectomy with standard regional lymphadenectomy is both safe and effective for achieving long-term survival. The zero perioperative mortality in this series is consistent with other series recently reported in the literature [5, 8, 12, 14] . These series have been conducted over the last 20 years, a period characterized by significant advances in imaging technology, surgical technique, anesthesia, critical care, and interventional radiology [17] . Overall 5-year survival rates for patients following pancreatoduodenectomy for ampullary carcinoma ranges from 38 to 67%, with a trend toward improved survival in more recent studies [1, 3, 4, 6, 8, 14] . Our 5-year overall survival rate of 64% is consistent with these current reports from high-volume centers [1, 3-8, 12, 14] . Because our patients were treated with an identical technique by a single team of experienced hepatobiliary-pancreatic surgeons over the last 18 years, this analysis may more accurately reflect the clinical outcome that can be expected using the current treatment. The high rate of R0 resection achieved with pancreatoduodenectomy with standard lymphadenectomy may make a contribution to improved survival. Various clinicopathologic factors have been reported to influence long-term survival following pancreatoduodenectomy for ampullary carcinoma, including absence of intraoperative transfusion [3] , tumor size [18] , histological tumor differentiation [19] , surgical margin [1, 20] , depth of tumor infiltration [5, 7, 9, 10] , pancreatic parenchymal invasion [4, 12] , lymph node metastasis [1, 4, 6, 9, 10, 12, 19] , lymphatic invasion [5, 12] , and perineural invasion [13, 14] . In our univariate analysis, T1 and T2 tumors, which are defined by the absence of pancreatic parenchymal invasion, negative lymph node metastasis, and absence of perineural invasion, significantly predicted improved postoperative survival. In our multivariate analysis, only absence of perineural invasion maintained its status as an independent predictor of long-term survival.
Although perineural invasion has frequently been recognized as a characteristic feature and indicator of poor prognosis in pancreatic adenocarcinoma [21] [22] [23] [24] , its relevance in ampullary carcinoma has been less well described. Only a few previous ampullary carcinoma series that underwent multivariate analysis included perineural invasion as a predictive factor for survival [1, 10, [12] [13] [14] . Thirty-three percent of our patients had perineural invasion, which is more frequent than the 15-22% reported in Fig. 3 Disease-specific survival rate of patients with and without perineural invasion of ampullary carcinoma who underwent pancreatoduodenectomy with standard regional lymphadenectomy. pn perineural invasion other series. Nakai et al. [13] reported that the incidence of microperineural invasion using immunohistochemical staining (56%) was higher than that of perineural invasion using hematoxylin and eosin staining, and that microperineural invasion is a prognostic factor for ampullary carcinoma. Our series is consistent with a series reported by Duffy et al. [14] in which ampullary carcinoma patients with perineural invasion in resected specimens portended a poor prognosis following pancreatoduodenectomy with lymphadenectomy. Ampullary carcinoma with perineural invasion may have a similar prognosis as pancreatic adenocarcinoma, in which the majority of patients have perineural invasion. The use of adjuvant therapy in patients with perineural invasion of ampullary carcinoma should be evaluated as a possible means of improving survival following potentially curative resection. Lymph node metastasis has been reported by several authors to be a poor prognostic factor for ampullary carcinoma [1, 4, 6, 9, 10, 12, 19] . In our series, nodal status was a prognostic factor by univariate analysis, but was not an independent prognostic factor by multivariate analysis. Thirty-three percent of our patients had lymph node involvement, which is similar to the 28-46% reported in other series [1, 3, 4, 6, 7, 9, 10, 14] . The 5-year survival rate of our patients with positive nodal status was 40%, which is higher than the 16-31% reported in other series, in which nodal status has been identified as a significant prognostic factor [1, 4, 6, 9] . In our series, an appropriate number of regional lymph nodes (median, 20) were surgically dissected and examined by experienced pathologists for each specimen. Sites and nature of recurrence in patients with R0 resection included six liver metastases, three peritoneal disseminations, and one local disease. The oncologic effect of identical and standard regional lymphadenectomy may explain why lymph node status was not an independent prognostic factor following surgery in this series.
The use of local resection for early ampullary carcinomas remains controversial. Some authors advocate local resection, i.e., ampullectomy for T1 lesions, with preoperative endoscopic ultrasound and intraoperative frozen section as the procedures of choice for identification of appropriate lesions [4, 25, 26] . Histologic evidence of invasion of the duodenal muscular layer has been shown to predict the presence of lymph node metastasis [27] . However, even endoscopic ultrasound can only accurately define the depth of invasion in 66-83% of cases [28] [29] [30] . Further, intraoperative frozen section examination cannot exclude infiltration of the margins of a local excision [31] . Moreover, recurrence rates as high as 60-75% following local resection for early ampullary carcinoma have been reported [19, 20, 25, 31] . In patients with a carcinoma in situ or a T1 carcinoma of the ampulla, 6-10% have lymph node involvement [32] . In our series, one patient with T1 moderately differentiated tubular adenocarcinoma had lymph node metastasis in the posterior pancreaticoduodenal nodes. Currently, standard pancreatoduodenectomy with lymphadenectomy can be safely performed with very low mortality and impressive longterm survival for ampullary carcinoma; thus, ampullectomy is not a good alternative even in early ampullary carcinoma, due to its diagnostic and curability limitations.
In conclusion, pancreatoduodenectomy with standard regional lymphadenectomy is a safe surgical procedure with acceptable long-term survival for ampullary carcinoma. The presence of perineural invasion following potential curative resection for ampullary carcinoma is a useful poor prognostic factor. The addition of adjuvant therapy to patients with perineural invasion should be evaluated as a possible means of improving long-term survival.
